Julie L. Bushman - 24 Oct 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for Julie Bushman pursuant to Power of Attorney previously filed.
Issuer symbol
TECH
Transactions as of
24 Oct 2024
Net transactions value
$0
Form type
4
Filing time
28 Oct 2024, 16:42:56 UTC
Previous filing
14 Mar 2024
Next filing
17 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Award $0 +1,462 +26% $0.000000 7,135 24 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Award $0 +3,511 $0.000000 3,511 24 Oct 2024 Common Stock 3,511 $68.37 Direct F1
holding TECH Stock Options (Right to Buy) 1,444 24 Oct 2024 Common Stock 1,444 $69.72 Direct
holding TECH Stock Options (Right to Buy) 6,028 24 Oct 2024 Common Stock 6,028 $63.92 Direct
holding TECH Stock Options (Right to Buy) 2,532 24 Oct 2024 Common Stock 2,532 $128.81 Direct
holding TECH Stock Options (Right to Buy) 3,460 24 Oct 2024 Common Stock 3,460 $73.94 Direct
holding TECH Stock Options (Right to Buy) 3,937 24 Oct 2024 Common Stock 3,937 $61.51 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.